Products for the nutraceutical and nutrition industries
Patent Information Greenhouse Solutions is the exclusive licensee of US Patent 6080401 to produce cannabis-derived nutraceuticals.
GH Solutions brings a patented technological advancement to the nutraceutical, functional beverage, and health food markets. As the exclusive licensee of US patent 6080401, we are the sole source of formulations that supercharge the benefits of botanicals like hemp seed oil with the incredible health and wellness effects of probiotics.
We chose the probiotic approach not only because of its intrinsic health benefits, but also because of its efficacy as a delivery mechanism. Probiotics enable the body to absorb botanical oils more quickly and effectively. Our method— licensed from one of the world’s leading probiotic researchers—positions us to develop an exciting portfolio of beneficial formulations for use as ingredients by nutritional supplement, food, and beverage manufacturers.
Partnering with GH Solutions is the pathway to developing products that offer the therapeutic benefits of hemp oil and probiotics synergistically, in a new, more effective way.
Functional Beverage Industry
The first commercial product featuring GH Solutions ingredients will be available at retailers nationwide beginning in 2016. We’ve partnered with Koios
, a major nootropics developer, on a new addition to its beverage product line. Widely known as a nootropic supplement developer, Koios makes products that support cognitive function and mental clarity.
Koios worked with GH Solutions in order to infuse its proprietary and hugely successful blend of nootropics with hemp oil. Marketed as a dietary supplement to enhance brain function, boost energy and burn fat, the newest Koios functional beverage is “Raspberry Wonder,” and it is just the beginning. Work is underway now to develop the next generation of Raspberry Wonder, which will use GH Solution’s patent protected process to suspend active probiotics in the beverage.
We are also engaged in research and development of a new probiotic hemp oil-infused cold-brew coffee beverage—another first of its kind.
Nutraceutical Supplements Industry
We are working with a major health supplement developer to produce water soluble, probiotic infused Phytocannabinoid oils an ingredient for nutraceutical product manufacturers. The water solubility of probiotics —another GH Solutions innovation— means that this ingredient could be integrated into any number of formulations, including capsules and foods, as well as beverages. A major American university is engaged in a full study of the compound to establish the health benefits of this new ingredient.
We expect to see hemp oils in a wide range of uses, and not just for people. It is increasingly popular for pet health care as well.
Support the immune system and speed nutrient absorption at the same time
Probiotics are live bacteria and microorganisms that, among other things, support the health and proper functioning of the digestive system. These “good” bacteria occur naturally in the human body and in power foods like yogurt, dark chocolate and miso soup. Just as antibiotics are taken to inhibit harmful bacteria, supplemental probiotics are taken to encourage the growth and action of good bacteria.
Although the benefits of probiotics have been understood by science for more than a century, it has been only over the past 20 years that health and wellness advocates have been intentional about introducing these helpful bacteria into nutritional supplements.
One of the earliest discoveries demonstrating that bacteria can improve human health was made by Dr. Metchnikoff, a Russian scientist, in 1907. Since then, there have been favorable reports about probiotics’ utility, including, for example, that lactobacillus acidophilus reduces colon cancer in humans. The ability of probiotics to boost the immune system in general has also been studied.
In 2011, Yale University reviewed the research on probiotics. It concluded that probiotics are most effective for (but not limited to) treating: childhood diarrhea, ulcerative colitis, and necrotizing enterocolitis (a type of infection and inflammation of the intestines mostly seen in infants). It has also been shown to prevent antibiotic-associated diarrhea and infectious diarrhea, pouchitis (an inflammation of the intestines that can follow intestinal surgery), and eczema associated with cow’s milk allergy. Probiotics are also used to treat symptoms of irritable bowel syndrome, vaginitis, and Crohn’s disease.
GH Solutions develops formulations incorporating probiotics that can mitigate digestive problems in existing health and wellness products, and can increase the efficacy and uptake of supplemental nutrition and nutraceuticals as well.
Committed to helping you incorporate the benefits of hemp
Hemp is one of the oldest plants to be cultivated by man—and for good reason. Its versatility is astounding. While hemp is used to manufacture paper, textiles, construction materials, plastics, and even biofuels our interest is in the oils refined from hemp seed.
A non-psychoactive form of cannabis—hemp is genetically distinct from marijuana. The hemp oils we use are legal in every US jurisdiction.
Hemp oil is an abundant source of alpha-linolenic acid. Alpha-linolenic acid is an omega-3 fatty acid, essential to proper organ function. It is similar to the omega-3 fatty acids found in fish oil, which can help prevent heart disease, arthritis and depression, according to the University of Maryland Medical Center. It can also help reduce low density lipoprotein cholesterol, the “bad” cholesterol that clogs arteries.
Hemp oil can be used for the treatment of minor health ailments and as a dietary supplement for the promotion of general good health. Hemp oil is considered one of the most useful natural supplements for the body due to its ability to provide several fatty acids that humans cannot manufacture on our own.
GH Solutions believes that the hemp oil and hydrolyzed hemp proteins, coupled with the proper probiotics, will greatly assist and improve the overall health and wellbeing of humans as well as animals.
Cannabidiol or CBD is a naturally occurring substance found in hemp plants. CBD oil is non-psychoactive and is actively being researched and applied in a number of therapeutic contexts, including Dravet Syndrome, multiple sclerosis, depression, and schizophrenia. CBD’s use in animal health care is already widespread.
Considering the broad spectrum of uses for CBD, GH Solutions’ future plans include developing and producing formulations to enhance the speed and effectiveness of CBD’s many benefits.
Rik J. Deitsch
Chairman and Chief Executive Officer
Rik J. Deitsch | Chairman and Chief Executive Officer
Rik J. Deitsch has been the President, Chief Executive Officer and a Director of Nutrapharma, a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases since November 7, 2002. From February 1998 through November 2002, Mr. Deitsch served as the President of NDA Consulting Inc., a biotechnology research group that provided consulting services to the pharmaceutical industry. NDA Consulting specialized in the research of peptides derived from Cone Snail venom, Cobra venom and Gila Monster venom. Mr. Deitsch holds both a B.S. in Chemistry and an M.S. in Biochemistry from Florida Atlantic University and has conducted clinical and laboratory research in collaboration with scientists at Duke University Medical Center and the Cleveland Clinic . Mr. Deitsch is an adjunct professor and teaches several courses for Florida Atlantic University’s College of Business and Continuing Education Department.
John George Michak III
John George Michak III | COO
As a Nordstrom’s credit communications planner from April 2013 to January 2014, Mr. Michak supported the development of business operational documents and drove the execution for all credit related customers facing collateral. Managed the collateral budget and worked with colleagues to identify and implement customer communications enhancements and or cost reduction opportunities for the company. While at Morgan Stanley Global Wealth Management from January 2012 to January 2013, Mr. Michak worked as a technology analyst, and as a strategic partner along with the firm’s business units and some of the world’s leading technology companies to redefine how Morgan Stanley does business in global financial markets that are extremely fast and vastly complex. While assisting the firm with the conversion effort of combining Smith Barney and Morgan Stanley to create Morgan Stanley Global Wealth Management Group. Mr. Michak also worked for Alpert Homes from March 2010 to January 2012 and helped manage relationships with sales center representatives in assigned communities and followed up regularly regarding prospects. He also assisted in managing new home construction sites start to finish.
Mr. Michak holds a liberal arts degree from Colorado State University as well as attended Kaplan real estate school in Denver. He has been working with global companies aiding in their growth and expansion since 2009.
Dr. M.S. Reddy
Dr. Reddy is founder and president of Denver-based American Dairy and Food Consulting Laboratories and International Media and Cultures (IMAC Inc.) which has ten manufacturing plants selling, products throughout the United States, Canada, Europe, India and Latin America. He was nominated for the Nobel Peace Prize in 2012, 2013 and 2014. He holds over 150 U.S. and international patents and has published over 70 scientific articles on dairy starter cultures, probiotics, pharmaceuticals, and complementary alternative medicines pertaining to Probiotics and has authored several books.
Dr. Reddy has served as a technical consultant to over 70 national and international companies all over the world including industry related Domino’s Pizza and Papa Johns. He has received many awards in scientific research, community service, and entrepreneurship including the Richard Hoyt award, Sigma-Xi Research award, Outstanding Scientist award, Entrepreneur and Businessman of the year award, International Entrepreneur award and the President Ronald Regan Gold Medal. He holds M.S. and Ph.D. degrees in food technology, microbiology and (virology) with honors and distinctions from Iowa State University.
Kyle W. Rost
Attorney for international Patents
Kyle W. Rost, Attorney for international Patents.
Mr. Rost holds the degree of Juris Doctor with Honors from the University of Texas and is a senior partner with the firm of Lewis & Rost, intellectual property lawyers with offices in Denver and northern Colorado. He specializes in practice before the U.S. Patent and Trademark Office and obtains patents worldwide through his network of leading attorneys in every major country around the globe. In addition, he has taught business law and served as an expert witness in numerous federal and state courts in both patent and trademark causes. Areas of patent expertise include environmental remediation, chemistry, pharmaceuticals, biotechnology, therapeutics, probiotics, and nutraceuticals. Some of the areas where he has secured protection for leading edge technologies include cleaning geothermal steam feeding power plants while increasing turbine output, localized cleaning of aquaculture waters by application of specialized biochemical feeds in proximity to the stock in a body of water, treating water supplies with easily renewed agents to remove heavy metals, synergistic combinations of pharmaceuticals and probiotics, and treating divided food products to impart superior handling characteristics.
Dr. Samba Reddy
Dr. Samba Reddy is a Professor of Neuroscience and Experimental Therapeutics in the College of Medicine at Texas A&M University– a premier institution in America and the largest university in Texas. Previously, Dr. Reddy worked as an Assistant Professor at North Carolina State University and has won several NIH grants for pharmacology research. He joined Texas A&M University in 2008 as an Associate Professor, receiving a promotion to Professor in 2012. He completed clinical pharmacy training and received board certification as Registered Pharmacist (RPh) in Texas. As an expert pharmacist, he gives lectures on clinical topics and organizes free community health camps. Dr. Reddy’s scientific publication record is recognized worldwide with over 120 published papers in international journals, exceeding 80 “first-authored” manuscripts in prime journals. His publications have been cited and widely referenced in the field with over 7000 citations and an overall h-index of 36. He has authored two of the leading textbooks in the field, Pharmacy Entrance and Pharmacy Quiz in addition to other book publications and participation in authoring chapters to major text books. He has given over 100 seminars and co- authored over 200 presentations worldwide.
Dr. Kevin Kjernisted
Dr. Kevin Kjernisted received his Medical Degree from the University of Manitoba in 1983. As a general practitioner for 5 years before completing training to be a psychiatrist at the University of Manitoba. For more than a decade Dr. Kjernisted was Medical Director of the Anxiety Disorders Clinic and Director of Research at St. Boniface General Hospital in the Department of Psychiatry, University of Manitoba before relocating to Vancouver, Canada where he is currently a Clinical Associate Professor of Psychiatry in the Faculty of Medicine at the University of British Columbia. Dr. Kjernisted has acted as principal investigator in over 35 clinical trials investigating compounds for mood disorders, anxiety disorders, schizophrenia, ADHD and weight management. His research interests also include the “mind-body connection” which involves interactions between the brain, the gut and the immune system (psychoneuroimmunology). Dr. Kjernisted has lectured extensively on this topic to peers at national and international meetings. Optimal treatment in his busy clinical practice involves complementary and alternative treatments including probiotics, exercise and nutraceuticals, along with medications and psychotherapy, in order to address excessive inflammation and oxidation which contribute to psychiatric illness, chronic pain, heart disease, liver disease, diabetes, inflammatory bowel disease, cancer and dementia.
GRSU Security Details
| ||Market Value1 ||$3,157,227 ||a/o Jan 20, 2017 |
| ||Authorized Shares ||Not Available |
| ||Outstanding Shares ||96,847,458 ||a/o Nov 14, 2016 |
| ||-Restricted ||Not Available |
| ||-Unrestricted ||Not Available |
| ||Held at DTC ||Not Available |
| ||Float ||60,000,000 ||a/o Nov 19, 2015 |
| ||Par Value ||0.001 |